Sonoma Pharmaceuticals, Inc.
(NASDAQ : SNOA)

( )
SNOA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 0.62%25.0814.1%$147.57m
ICLRICON plc -1.55%251.952.8%$141.91m
HZNPHorizon Therapeutics Plc -0.17%86.425.4%$113.85m
BHCBausch Health Cos., Inc. 0.62%25.080.0%$107.94m
CTLTCatalent, Inc. 0.06%102.082.0%$107.71m
JAZZJazz Pharmaceuticals Plc -1.70%136.762.1%$87.59m
SAVACassava Sciences, Inc. -2.89%36.330.0%$85.54m
UTHRUnited Therapeutics Corp. 0.05%200.0613.9%$78.87m
ZGNXZogenix, Inc. -0.08%25.987.5%$77.91m
PRGOPerrigo Co. Plc -2.27%38.846.9%$49.22m
ARGXargenx SE -0.79%279.250.0%$48.42m
PCRXPacira Biosciences, Inc. -0.89%63.439.8%$28.67m
BRBRBellRing Brands, Inc. 0.29%24.330.0%$26.08m
IRWDIronwood Pharmaceuticals, Inc. 0.64%10.999.5%$22.81m
SAGESAGE Therapeutics, Inc. -1.57%38.217.6%$17.91m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in developing and producing Stabilized Hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. Its products educe infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA.